From: Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer
Concentration of MnCl2[M]
Cell viability [%]
0 (control)
95
0.02
91.7
0.025
83
0.03
91
0.035
90
0.04
32
0.045
23